Close X
Monday, November 25, 2024
ADVT 
National

Senior officer faces military charges

Darpan News Desk The Canadian Press, 21 Jul, 2022 10:24 AM
  • Senior officer faces military charges

OTTAWA - The military police have charged a senior officer in the Canadian Armed Forces after an investigation into allegations of an inappropriate relationship with a subordinate.

The office of Canada's military police chief announced on Wednesday that Lt.-Gen. Steven Whelan is facing two counts under the National Defence Act related to "conduct to the prejudice of good order and discipline."

Whelan stepped aside from his role as head of the Canadian military's human resources last October due to an investigation by military police into "historic" allegations of sexual misconduct.

Whelan, who has previously denied wrongdoing, could not immediately be reached for comment.

Whelan took over as head of human resources after Vice-Admiral Haydn Edmundson stepped down from the role due to a police investigation.

In December, Edmundson was charged with one count of sexual assault and one count of indecent acts. His lawyer, Brian Greenspan, denied the allegations at the time.

Edmundson's trial is set for August 2023 and will be heard in the civilian court system.

Defence Minister Anita Anand said last November the Forces would start transferring cases involving criminal sexual offences to civilian police forces and courts on an interim basis.

Wednesday's statement on the charges laid against Whelan said the Canadian Forces National Investigation Service's probe did not reveal any supporting evidence for laying criminal charges, as the allegations relate to offences "specific to the military context" that would not have been investigated by civilian police.

 

MORE National ARTICLES

Twitter board to evaluate Musk's 'unsolicited, non-binding' $43B offer

Twitter board to evaluate Musk's 'unsolicited, non-binding' $43B offer
Earlier in the day, Musk made an offer to buy 100 per cent of Twitter at $54.20 per share, a 54 per cent premium over the closing price of Twitter on January 28, 2022, the trading day before Musk began investing in the company. This is a 38 per cent premium over the closing price of Twitter on April 1, 2022, the trading day before Musk's investment in Twitter was publicly announced.

Twitter board to evaluate Musk's 'unsolicited, non-binding' $43B offer

Feds to target need with housing cash, Hussen says

Feds to target need with housing cash, Hussen says
Housing Minister Ahmed Hussen said the budget's plan to double housing starts over the next decade will aim to incentivize the construction of units needed by seniors who are downsizing, for example, as well as newcomer families.

Feds to target need with housing cash, Hussen says

B.C. fires, floods add uncertainty to spring thaw

B.C. fires, floods add uncertainty to spring thaw
Major wildfires, droughts and mudslides last year dramatically altered the landscape, raising questions about the river's ability to handle the spring thaw, or freshet.

B.C. fires, floods add uncertainty to spring thaw

Confirmed outbreak of avian flu in B.C.

Confirmed outbreak of avian flu in B.C.
She says all poultry producers, including backyard poultry owners, are advised to increase their biosecurity practices and carefully monitor their flocks for any sign of illness.

Confirmed outbreak of avian flu in B.C.

Singh demands Indian PM stop anti-Muslim hate

Singh demands Indian PM stop anti-Muslim hate
In an outspoken intervention into Indian politics, Singh says he is deeply concerned by images, videos and targeted threats of violence against the country's Muslim community.    

Singh demands Indian PM stop anti-Muslim hate

Health Canada approves COVID-19 prevention drug

Health Canada approves COVID-19 prevention drug
The drug, named Evusheld, is intended for people who cannot receive a typical vaccine or for whom vaccines alone won't provide enough immunity. AstraZeneca says the drug is not a substitute for vaccination against COVID-19 for most people.    

Health Canada approves COVID-19 prevention drug